CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

DynamX Bioadaptor is a new type of coronary implant designed [...]

By |2023-05-17T16:19:29+00:00May 17, 2023|3rd Party Medical Device Industry News|Comments Off on EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)
Go to Top